I confess, I really enjoy it when somewhat grandiose programs that are supposed to transform health care pretty much fall far short of the projected effects. So it is with pay-for-performance. An article in Health Affairs looks at the Medicare hospital pay-for-performance initiatives and expresses concerns about their operation and effects. (HA Article) Three primary programs include the Hospital-acquired Conditions Reduction program, under which hospitals must avoid patients contracting certain infections or other conditions or get a payment reduction; the Value-Based Purchasing program, which also adjusts payment in part based on quality measures; and the Hospital Readmissions Reduction initiative, which we have frequently discussed. By 2017 hospitals could lose as much as 6% of base payments from Medicare under these three programs. As you might expect there can be overlap in the quality measures in the three programs. The value-based purchasing program is budget-neutral but in 2015 almost 45% of hospitals lost some reimbursement, generally small amounts. The readmission program is not budget-neutral and is ensnaring increasing numbers of hospitals, which in total lost over $420 million in Medicare reimbursements for 2015. Many of the penalized hospitals under this program and the hospital-acquired conditions program were major institutions with otherwise good markers of quality of care. As the article recites, many health care experts have criticized the design of the measures used in these programs, the failure to have adequate case-mix adjustment, the inconsistency in data collection and reporting that makes consistency of results unlikely and the administrative burden and costs imposed upon the hospitals. It is also very difficult to attribute any improvement in quality on these programs as opposed to other factors. All these issues have been presented to CMS, which generally seems to just ignore them.
Medicare’s Hospital Pay-for-Performance Programs
No Comments
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
Variation in Health Spending
February 16, 2025
Variation in Health Spending
Another interesting analysis of geographic variation in health spending.
Commentary
All Quiet on the Western Front
February 15, 2025
All Quiet on the Western Front
The pre-eminent description of war's impact on those who must fight it was written after…
Commentary
Yesterday’s 30-year US Bond Auction Did Not Go Well
February 14, 2025
Yesterday’s 30-year US Bond Auction Did Not Go Well
Warning signs aplenty if Congress does not get its act together on deficit reduction.